Structure and function of a recombinant von willebrand factor drug candidate

Seminars in Thrombosis and Hemostasis

Volumn 36, Issue 5, 2010, Pages 510-521

  Turecek, Peter L ^a   Schrenk, Gerald ^a   Rottensteiner, Hanspeter ^a   Varadi, Katalin ^a   Bevers, Edouard ^c   Lenting, Peter ^d   Ilk, Nicola ^b   Sleytr, Uwe B ^b   Ehrlich, Hartmut J ^a   Schwarz, Hans Peter ^a  

^a BAXTER BIOSCIENCE   (Austria)

^b UNIVERSITY OF NATURAL RESOURCES AND LIFE SCIENCES   (Austria)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d Dept Environ Med Natl Inst Publ HIth   (Norway)

Author keywords

hemophilia; platelet binding; Recombinant von Willebrand factor; structure; von Willebrand disease; VWD; VWF

Indexed keywords

COLLAGEN; MATRIX PROTEIN; RECOMBINANT PROTEIN; RECOMBINANT VON WILLEBRAND FACTOR; RISTOCETIN; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

BINDING AFFINITY; DRUG ACTIVITY; DRUG STRUCTURE; ELECTRON MICROSCOPY; HUMAN; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN MULTIMERIZATION; PROTEIN PROCESSING; RECEPTOR BINDING; REVIEW; SHEAR STRESS; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; ULTRASTRUCTURE ANALYSIS AND ELECTRON MICROSCOPY; ANIMAL; CHEMISTRY; VON WILLEBRAND DISEASES;

ANIMALS; HUMANS; RECOMBINANT PROTEINS; VON WILLEBRAND DISEASES; VON WILLEBRAND FACTOR;

EID: 77954877699     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0030-1255445     Document Type: Review

References (41)

1. Plaimauer B, Schlokat U, Turecek P L. et al. Recombinant von Willebrand factor: preclinical development. Semin Thromb Hemost 2001 27 (4) 395-403
2. Budde U, Schneppenheim R. Von Willebrand factor and von Willebrand disease. Rev Clin Exp Hematol 2001 5 (4) 335-368
3. Sadler J E. von Willebrand factor assembly and secretion. J Thromb Haemost 2009 7 (Suppl 1) 24-27
4. Ruggeri Z M. The role of von Willebrand factor in thrombus formation. Thromb Res 2007 120 (Suppl 1) S5-S9
5. Reininger A J. VWF attributesimpact on thrombus formation. Thromb Res 2008 122 (Suppl 4) S9-S13
6. Reininger A J. Function of von Willebrand factor in haemostasis and thrombosis. Haemophilia 2008 14 (Suppl 5) 11-26
7. Sadler J E. Biochemistry and genetics of von Willebrand factor. Annu Rev Biochem 1998 67 395-424
8. Kroll M H., Hellums J D., McIntire L V., Schafer A I., Moake J L. Platelets and shear stress. Blood 1996 88 (5) 1525-1541
9. Goto S, Salomon D R., Ikeda Y, Ruggeri Z M. Characterization of the unique mechanism mediating the shear-dependent binding of soluble von Willebrand factor to platelets. J Biol Chem 1995 270 (40) 23352-23361
10. Lenting P J., van Mourik J A., Mertens K. The life cycle of coagulation factor VIII in view of its structure and function. Blood 1998 92 (11) 3983-3996
11. Weiss H J., Sussman I I., Hoyer L W. Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand's disease. J Clin Invest 1977 60 (2) 390-404
12. Denis C V., Christophe O D., Oortwijn B D., Lenting P J. Clearance of von Willebrand factor. Thromb Haemost 2008 99 (2) 271-278
13. Fischer B E. Recombinant von Willebrand factor: potential therapeutic use. J Thromb Thrombolysis 1999 8 (3) 197-205
14. Turecek P L., Mitterer A, Matthiessen H P. et al. Development of a plasma- and albumin-free recombinant von Willebrand factor. Hamostaseologie 2009 29 (Suppl 1) S32-S38
15. Blanchette V S., Shapiro A D., Liesner R J. et al, rAHF-PFM Clinical Study Group. Plasma and albumin-free recombinant factor VIII: pharmacokinetics, efficacy and safety in previously treated pediatric patients. J Thromb Haemost 2008 6 (8) 1319-1326
16. Fretto L J., Fowler W E., McCaslin D R., Erickson H P., McKee P A. Substructure of human von Willebrand factor. Proteolysis by V8 and characterization of two functional domains. J Biol Chem 1986 261 (33) 15679-15689
17. Ohmori K, Fretto L J., Harrison R L., Switzer M E., Erickson H P., McKee P A. Electron microscopy of human factor VIII/Von Willebrand glycoprotein: effect of reducing reagents on structure and function. J Cell Biol 1982 95 (2 Pt 1) 632-640
18. Ruggeri Z M., Zimmerman T S. The complex multimeric composition of factor VIII/von Willebrand factor. Blood 1981 57 (6) 1140-1143
19. Aihara M, Sawada Y, Ueno K et al. Visualization of von Willebrand factor multimers by immunoenzymatic stain using avidin-biotin peroxidase complex. Thromb Haemost 1986 55 (2) 263-267
20. Sadler J E. Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura. Blood 2008 112 (1) 11-18
21. Franchini M, Mannucci P M. Von Willebrand factor: another janus-faced hemostasis protein. Semin Thromb Hemost 2008 34 (7) 663-669
22. Furlan M, Robles R, Lämmle B. Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis. Blood 1996 87 (10) 4223-4234
23. Varadi K, Rottensteiner H, Vejda S et al. Species-dependent variability of ADAMTS13-mediated proteolysis of human recombinant von Willebrand factor. J Thromb Haemost 2009 7 (7) 1134-1142
24. Berndt M C., Ward C M., Booth W J., Castaldi P A., Mazurov A V., Andrews R K. Identification of aspartic acid 514 through glutamic acid 542 as a glycoprotein Ib-IX complex receptor recognition sequence in von Willebrand factor. Mechanism of modulation of von Willebrand factor by ristocetin and botrocetin. Biochemistry 1992 31 (45) 11144-11151
25. Hulstein J J., de Groot P G., Silence K, Veyradier A, Fijnheer R, Lenting P J. A novel nanobody that detects the gain-of-function phenotype of von Willebrand factor in ADAMTS13 deficiency and von Willebrand disease type 2B. Blood 2005 106 (9) 3035-3042
26. Bendetowicz A V., Morris J A., Wise R J., Gilbert G E., Kaufman R J. Binding of factor VIII to von Willebrand factor is enabled by cleavage of the von Willebrand factor propeptide and enhanced by formation of disulfide-linked multimers. Blood 1998 92 (2) 529-538
27. Vlot A J., Koppelman S J., Berg van den M H., Bouma B N., Sixma J J. The affinity and stoichiometry of binding of human factor VIII to von Willebrand factor. Blood 1995 85 (11) 3150-3157
28. Sadler J E. von Willebrand factor: two sides of a coin. J Thromb Haemost 2005 3 (8) 1702-1709
29. Favaloro E J. Clinical utility of the PFA-100. Semin Thromb Hemost 2008 34 (8) 709-733
30. Soslau G, Class R, Morgan D A. et al. Unique pathway of thrombin-induced platelet aggregation mediated by glycoprotein Ib. J Biol Chem 2001 276 (24) 21173-21183
31. Sakariassen K S., Muggli R, Baumgartner H R. Measurements of platelet interaction with components of the vessel wall in flowing blood. Methods Enzymol 1989 169 37-70
32. Ruggeri Z M., Mendolicchio G L. Adhesion mechanisms in platelet function. Circ Res 2007 100 (12) 1673-1685
33. Federici A B. The factor VIII/von Willebrand factor complex: basic and clinical issues. Haematologica 2003 88 (6) EREP02
34. Kokame K, Matsumoto M, Soejima K et al. Mutations and common polymorphisms in ADAMTS13 gene responsible for von Willebrand factor-cleaving protease activity. Proc Natl Acad Sci U S A 2002 99 (18) 11902-11907
35. Levy G G., Nichols W C., Lian E C. et al. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature 2001 413 (6855) 488-494
36. Plaimauer B, Zimmermann K, Völkel D et al. Cloning, expression, and functional characterization of the von Willebrand factor-cleaving protease (ADAMTS13). Blood 2002 100 (10) 3626-3632
37. Turecek P L., Furlan M, Lämmle B et al. Cleavage of recombinant von Willebrand Factor (vWF) by a vWF-depolymerizing protease. Blood 1996 88 (Suppl 1) 326a Abstract 1291
38. Lethagen S, Carlson M, Hillarp A. A comparative in vitro evaluation of six von Willebrand factor concentrates. Haemophilia 2004 10 (3) 243-249
39. Budde U, Metzner H J., Müller H G. Comparative analysis and classification of von Willebrand factor/factor VIII concentrates: impact on treatment of patients with von Willebrand disease. Semin Thromb Hemost 2006 32 (6) 626-635
40. Hubbard A R. von Willebrand factor standards for plasma and concentrate testing. Semin Thromb Hemost 2006 32 (5) 522-528
41. Muchitsch E-M, Dietrich B, Rottensteiner H, Auer W, Nehrbass D, Gritsch H, Ehrlich H J., Schwarz H P., Turecek P L. Non-clinical testing of human recombinant von Willebrand factor: ADAMTS13 cleavage capacity in animals as criterion for species suitability. Semin Thromb Hemost 2010 35 (5) 522-528